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Fig 1. Erythrodermic CD81 pseudolymphoma induced by
infliximab.
Fig 2. Erythrodermic CD81 pseudolymphoma resolved
after 4 months of cyclosporine.
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e150 Lettersresulted from infliximab treatment4; the other case
was induced by etanercept.5 However, unlike the
present case, erythroderma was not associated with
the reported cases, which could explain why the
pseudolymphomatous reaction resolved after
withdrawal of the drug in both cases. Moreover, in
the second case described, relapse did not occur
after the administration of another TNF inhibitor,
adalimumab. Because our patient developed
an erythrodermic reaction, treatment with TNF
inhibitors was halted. Cyclosporine was used as
rescue therapy and resulted in dramatic improve-
ment without any significant side effects.
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Aquagenic wrinkling: A unique facial
presentation
To the Editor: Aquagenic wrinkling of the palms
(AWP) is characterized by the formation of white
papules and plaques on the palms and fingers after
brief exposure to water. We extend the clinical
phenotype by describing a healthy adolescent girl
with aquagenic wrinkling (AW) of the face and
palms.
A 16-year-old girl presented with recurrent skin
changes of 18 months’ duration. She described the
abrupt appearance of superficial, whitish material on
her cheeks upon exposure to sweat and tap water,
which resolved within hours. No preceding medica-
tions or supplements were noted. Prior treatments
including topical antibiotics, corticosteroids, and
emollients were ineffective.
Application of tap water to the left cheek induced
off-white hyperkeratosis and wrinkling in less
than 3 minutes (Fig 1). Immersion of the right
hand in water for 4 minutes caused mild AW.
Testing for 97 common mutations in the cystic
Fig 1. Facial aquagenic wrinkling. Application of tap
water soaked gauze to the left cheek for less than 3
minutes elicited off-white, superficial desquamation
confined to areas of contact with water.
Fig 2. Facial aquagenic wrinkling. Clinically normal skin
despite application of tap water soaked gauze following
continued application of aluminum magnesium stearate
hydroxide barrier cream.
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including DF508, was negative.
A presumptive diagnosis of AW of the face was
made. Topical aluminum chloride 6.25% solution to
be applied nightly was prescribed and the patient
was instructed to wash her face twice daily with
normal saline. These interventions helped but did
not eliminate her symptoms. Complete resolution
occurred when aluminum chloride was replaced
with aluminum magnesium hydroxide stearate bar-
rier cream (Tetrix, CORIA Laboratories) (Fig 2). This
creamwas applied twice daily and tapered to daily as
needed; she was able to discontinue all treatment
after 3 months.
Aquagenic wrinkling of the palms (synonyms:
transient reactive papulotranslucent acrokera-
toderma, aquagenic palmoplantar keratoderma,aquagenic syringeal acrokeratoderma) is an un-
common disorder that was first recognized by
Elliot in patients with cystic fibrosis (CF) and is
distinct from normal wrinkling of the skin.1 The
majority of CF patients experience some form of
chronic AWP.2 The phenomenon may also be
idiopathic and is seen in patients with marasmus,
atopic dermatitis or hyperhidrosis. Several drugs
can induce AWP, including nonsteroidal anti-
inflammatory agents, angiotensin-converting
enzyme inhibitors, and angiotensin-receptor
blockers. Variants of AWP not associated with CF
tend to be transitory and eventually remit. To our
knowledge, there are no previous reports of AW at
other anatomic sites.
The pathophysiology underlying AW is unknown.
A defect in the stratum corneum altering water
retention has been proposed.3 Studies have shown
that homozygosity of the DF508 mutation in
CFTR and the degree of transepidermal water loss
correlate with severity of wrinkling; sweat chloride
levels appear unrelated.2 Aberrant expression of
aquaporin-5 may also contribute to AWP, suggesting
a multifactorial pathogenesis.4
Treatment of AWP includes creating a barrier
against water influx into the stratum corneum.
Aluminum chloride,3,5 salicylic acid 20% in petro-
latum, and botulinum toxin injections have proven
helpful in selected cases.5 Our patient with facial AW
experienced symptomatic relief and a durable
clinical remission with a combination of aluminum
magnesium stearate hydroxide barrier cream and
isotonic saline for cleansing. It remains unclear
whether treatment induced the remission or
controlled her symptoms until spontaneous remission
occurred.3
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lymphoma in a patient with psoriatic arthritis
treated with etanercept
To the Editor: Primary thyroid marginal zone B-cell
lymphoma is a very rare type of lymphoma that
usually develops in patients with autoimmune
thyroiditis.1 There are previous reports of diffuse
large B-cell lymphoma and several subtypes of T-cell
lymphomas possibly associated with etanercept,2,3
but marginal zone B-cell lymphoma in the thyroid is
not reported to our knowledge. We present a rare
case of primary thyroid marginal zone B-cell lym-
phoma in a patient with psoriasis and psoriatic
arthritis using etanercept for 4 years.
A 58-year-old woman presented with a rapidly
growing mass on the front of her neck. Twenty-six
years previously, she was given the diagnosis of
psoriasis based on the presence of erythematous
scaly plaques on her entire body. Despite treatmentFig 1. Primary thyroid marginal zone B-cell
heterogeneous cells such as small lymphocytes,
with foamy nuclei and abundant cytoplasm withou
positive stain in the cytoplasm of tumor cells (B).
original magnifications: A, 3400; B, 3200.)with methotrexate (MTX), cyclosporine, and photo-
therapy, skin lesions and arthralgia of the hand and
foot persisted. She was referred to the rheumatology
department and given the diagnosis of psoriatic
arthritis based on classification criteria for psoriatic
arthritis (CASPAR) criteria. She received etanercept
(50 mg per week) in combination with MTX (10 mg
per week) for 4 years. Her skin lesions and arthralgia
improved over time, and nomajor adverse event was
noted in association with the etanercept use.
Neck computed tomography revealed a diffuse
enlargement of the thyroid gland. Her thyroid-
stimulating hormone level was elevated at 14.11
mIU/mL (normal, 0.32-5.00 mIU/mL) and other thy-
roid function values were within normal ranges. No
evidence of autoimmune thyroiditis was observed.
Thyroid fine-needle aspiration revealed polymor-
phous lymphocytes and a few atypical lymphocytes.
The patient underwent a right hemithyroidectomy for
a suspected thyroid lymphoid neoplasm. The final
pathology on the surgical specimen showed dense
lymphoid infiltrate containing multiple lymphoid
follicles with germinal centers. The tumor cell
consisted of centrocyte-like cells, small lymphocytes,
plasma cells, and scattered eosinophils (Fig 1, A).
They were positive for CD20, B-cell lymphoma
(BCL)-2, and kappa and lambda light chain but no
expression of CD3, CD10, and BCL-6, and the
germinal centers were highlighted with CD21. She
was given the diagnosis of low-grade B-cell
lymphoma consistent with marginal zone B-cell
lymphoma. She then discontinued etanercept and
MTX and received 3 cycles of adjuvant chemotherapy
with rituximab, cyclophosphamide, vincristine, and
prednisolone and 36 Gy total of radiotherapy. No
evidenceof lymphomaprogressionwasdetectedover
12 months. However, 2 weeks after cessation oflymphoma. Dense infiltration of mixed
eosinophils, plasma cells, and large cells
t normal structures of the thyroid gland (A);
(A, Hematoxylin-eosin stain; B: BCL-2 stain;
